FRANCISCO
CASQUERO OCIO
Investigador/a en el periodo 2001-2012
JON
CACICEDO FERNANDEZ DE BOBADILLA
PROFESORADO ASOCIADO
Publicaciones en las que colabora con JON CACICEDO FERNANDEZ DE BOBADILLA (20)
2022
-
Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy
Reports of Practical Oncology and Radiotherapy, Vol. 27, Núm. 3, pp. 428-439
2021
-
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: Toxicity, prostatespecific antigen kinetics, and cancer control
Journal of Contemporary Brachytherapy, Vol. 13, Núm. 1, pp. 12-17
2020
-
MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
Clinical and Translational Radiation Oncology, Vol. 24, pp. 135-139
-
Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study
Journal of Medical Imaging and Radiation Oncology, Vol. 64, Núm. 6, pp. 859-865
-
Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial
Radiotherapy and Oncology, Vol. 146, pp. 16-20
2019
-
Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study
Radiotherapy and Oncology, Vol. 135, pp. 13-18
-
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT
European Journal of Cancer Care, Vol. 28, Núm. 5
2018
-
Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?
Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584
-
Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial
Radiotherapy and Oncology, Vol. 126, Núm. 2, pp. 278-282
-
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 101, Núm. 5, pp. 1172-1178
2016
-
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist
British Journal of Radiology, Vol. 89, Núm. 1067
-
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
Journal of Contemporary Brachytherapy, Vol. 8, Núm. 6, pp. 477-483
2015
-
Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: Multicenter prospective observational study
BMC Palliative Care, Vol. 14, Núm. 1
2014
-
A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy
Chinese Journal of Cancer, Vol. 33, Núm. 4, pp. 204-210
-
A prospective analysis of inter- and intrafractional errors to calculate CTV to PTV margins in head and neck patients
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 113-120
-
Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy
Journal of Contemporary Brachytherapy, Vol. 6, Núm. 2, pp. 154-160
-
The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach
Cancer Treatment Reviews, Vol. 40, Núm. 1, pp. 178-189
2013
-
Definitive radiotherapy for T1 glottic squamous cell carcinoma: A 15-year Cruces University Hospital experience
Clinical and Translational Oncology, Vol. 15, Núm. 11, pp. 925-931
2012
-
Detection of risk factors that influence weight loss in patients undergoing radiotherapy
Reports of Practical Oncology and Radiotherapy, Vol. 17, Núm. 5, pp. 269-275
-
Smartphones and tablets: Reshaping radiation oncologists' lives
Reports of Practical Oncology and Radiotherapy, Vol. 17, Núm. 5, pp. 276-280